loadpatents
name:-0.034138917922974
name:-0.017347097396851
name:-0.014349937438965
Luke; George P. Patent Filings

Luke; George P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Luke; George P..The latest application filed is for "salts of (s)-(5-cyclobutoxy-2-methyl-6-(1-(piperidin-4-yl)-1h-pyrazol-4-yl- )-3,4-dihydroquinolin-1(2h)-yl)(cyclopropyl)methanone and solid forms thereof".

Company Profile
13.22.30
  • Luke; George P. - Clinton CT
  • Luke; George P. - Branford CT
  • Luke; George P. - Lexington MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone
Grant 11,267,805 - Luke , et al. March 8, 2
2022-03-08
Tetrahydroquinoline compositions as BET bromodomain inhibitors
Grant 11,111,229 - Bair , et al. September 7, 2
2021-09-07
Salts Of (s)-(5-cyclobutoxy-2-methyl-6-(1-(piperidin-4-yl)-1h-pyrazol-4-yl- )-3,4-dihydroquinolin-1(2h)-yl)(cyclopropyl)methanone And Solid Forms Thereof
App 20210261528 - Luke; George P.
2021-08-26
Benzopiperazine compositions as BET bromodomain inhibitors
Grant 11,084,831 - Bair , et al. August 10, 2
2021-08-10
Solid Forms Of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl- -6-oxo-1,6-dihydropyridine-2-carbonitrile
App 20210177829 - Luke; George P. ;   et al.
2021-06-17
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl- -6-oxo-1,6-dihydropyridine-2-carbonitrile
Grant 10,959,994 - Luke , et al. March 30, 2
2021-03-30
SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZINE-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE
App 20200392114 - LUKE; George P. ;   et al.
2020-12-17
Tetrahydroquinoline Compositions As Bet Bromodomain Inhibitors
App 20200369642 - Bair; Kenneth W. ;   et al.
2020-11-26
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(- 1-hydroxycyclopropyl)methanone
Grant 10,793,554 - Luke , et al. October 6, 2
2020-10-06
Benzopiperazine compositions as BET bromodomain inhibitors
Grant 10,703,764 - Bair , et al.
2020-07-07
SOLID FORMS OF 4-(2-FLUORO-4-(1-METHYL-1H-BENZO[d]IMIDAZOL-5-YL)BENZOYL)PIPERAZIN-1-YL)(- 1-HYDROXYCYCLOPROPYL)METHANONE
App 20200131155 - LUKE; George P. ;   et al.
2020-04-30
Tetrahydroquinoline compositions as bet bromodomain inhibitors
Grant 10,611,750 - Bair , et al.
2020-04-07
Solid Forms Of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl- -6-oxo-1,6-dihydropyridine-2-carbonitr
App 20200085815 - Luke; George P. ;   et al.
2020-03-19
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl- -6-oxo-1,6-dihydropyridine-2-carbonitrile
Grant 10,532,047 - Luke Ja
2020-01-14
Solid Forms Of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl- -6-oxo-1,6-dihydropyridine-2-carbonitr
App 20190350920 - Luke; George P. ;   et al.
2019-11-21
Benzopiperazine Compositions As Bet Bromodomain Inhibitors
App 20190330233 - Bair; Kenneth W. ;   et al.
2019-10-31
Benzopiperazine compositions as BET bromodomain inhibitors
Grant 10,377,769 - Bair , et al. A
2019-08-13
Tetrahydroquinoline compositions as BET bromodomain inhibitors
Grant 10,336,722 - Bair , et al.
2019-07-02
Tetrahydroquinoline Compositions As Bet Bromodomain Inhibitors
App 20190127347 - Bair; Kenneth W. ;   et al.
2019-05-02
Benzopiperazine Compositions As Bet Bromodomain Inhibitors
App 20180312524 - Bair; Kenneth W. ;   et al.
2018-11-01
Tetrahydroquinoline Compositions As Bet Bromodomain Inhibitors
App 20180215766 - Bair; Kenneth W. ;   et al.
2018-08-02
Tetrahydroquinoline Compositions As Bet Bromodomain Inhibitors
App 20160256448 - BAIR; Kenneth W. ;   et al.
2016-09-08
Benzopiperazine Compositions As Bet Bromodomain Inhibitors
App 20160256458 - BAIR; Kenneth W. ;   et al.
2016-09-08
Benzopiperazine Compositions As Bet Bromodomain Inhibitors
App 20160257699 - BAIR; Kenneth W. ;   et al.
2016-09-08
Tetrahydroquinoline Compositions As Bet Bromodomain Inhibitors
App 20160257692 - BAIR; Kenneth W. ;   et al.
2016-09-08
Benzopiperazine compositions as BET bromodomain inhibitors
Grant 9,422,281 - Bair , et al. August 23, 2
2016-08-23
Tetrahydroquinoline compositions as BET bromodomain inhibitors
Grant 9,388,161 - Bair , et al. July 12, 2
2016-07-12
Benzopiperazine Compositions As Bet Bromodomain Inhibitors
App 20150232465 - BAIR; Kenneth W. ;   et al.
2015-08-20
Tetrahydroquinoline Compositions As Bet Bromodomain Inhibitors
App 20150232445 - BAIR; Kenneth W. ;   et al.
2015-08-20
Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones
Grant 8,466,296 - Wang , et al. June 18, 2
2013-06-18
Aryl imidazoles and related compounds as C5a receptor modulators
Grant 8,119,665 - Luke , et al. February 21, 2
2012-02-21
Benzimidazole and Pyridylimidazole Derivatives
App 20100267698 - Li; Guiying ;   et al.
2010-10-21
COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONES
App 20100217012 - Wang; Zhe-qing ;   et al.
2010-08-26
Benzimidazole and pyridylimidazole derivatives
Grant 7,642,267 - Li , et al. January 5, 2
2010-01-05
Benzimidazole and Pyridylimidazole Derivatives
App 20080227793 - Li; Guiying ;   et al.
2008-09-18
Benzimidazole and pyridylimidazole derivatives
Grant 7,300,945 - Li , et al. November 27, 2
2007-11-27
Substituted 1-Benzyl-4-Substituted Piperazine Analogues
App 20070249616 - Hutchison; Alan J. ;   et al.
2007-10-25
New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators
App 20070208048 - Luke; George P. ;   et al.
2007-09-06
Substituted 1-benzyl-4-substituted piperazine analogues
Grant 7,253,168 - Hutchison , et al. August 7, 2
2007-08-07
Substituted 1-benzyl-4-substituted piperazine analogues
App 20060142301 - Hutchison; Alan J. ;   et al.
2006-06-29
Benzimidazole and pyridylimidazole derivatives
App 20060025425 - Li; Guiying ;   et al.
2006-02-02
Aryl-substituted piperazine derivatives
App 20060009456 - Hutchinson; Alan J. ;   et al.
2006-01-12
Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
App 20050239791 - Hutchison, Alan J. ;   et al.
2005-10-27
Substituted ring-fused imidazole derivative: GABAA receptors ligands
Grant 6,916,827 - Maynard , et al. July 12, 2
2005-07-12
Aryl imidazoles and related compounds as C5a receptor modulators
App 20040116424 - Luke, George P. ;   et al.
2004-06-17
Substituted ring-fused imidazole derivative: GABAA receptors ligands
App 20040014780 - Maynard, George D. ;   et al.
2004-01-22
Signal transduction inhibitors, compositions containing them
Grant 6,576,766 - Weigele , et al. June 10, 2
2003-06-10
Benzimidazole and pyridylimidazole derivatives
App 20030069257 - Li, Guiying ;   et al.
2003-04-10
Novel heterocycles
App 20020103161 - Weigele, Manfred ;   et al.
2002-08-01
Compounds useful to treat retroviral infections
Grant 6,169,181 - Romines , et al. January 2, 2
2001-01-02
Pyranone compounds useful to treat retroviral infections
Grant 5,852,195 - Romines , et al. December 22, 1
1998-12-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed